Abstract
The limited availability of human heart tissue and its complex cell composition are major limiting factors for the reliable testing of drug efficacy and toxicity. Recently, we developed functional human and pig heart slice biomimetic culture systems that preserve the viability and functionality of 300 μm heart slices for up to 6 days. Here, we tested the reliability of this culture system for testing the cardiotoxicity of anti-cancer drugs. We tested three anti-cancer drugs (doxorubicin, trastuzumab, and sunitinib) with known different mechanisms of cardiotoxicity at three concentrations and assessed the effect of these drugs on heart slice viability, structure, function and gene expression. Slices incubated with any of these drugs for 48 h showed diminished in viability as well as loss of cardiomyocyte structure and function. Mechanistically, RNA sequencing of doxorubicin-treated tissues demonstrated a significant downregulation of cardiac genes and upregulation of oxidative stress responses. Trastuzumab treatment downregulated cardiac muscle contraction-related genes consistent with its clinically known effect on cardiomyocytes. Interestingly, sunitinib treatment resulted in significant downregulation of angiogenesis-related genes, in line with its mechanism of action. Similar to hiPS-derived-cardiomyocytes, heart slices recapitulated the expected toxicity of doxorubicin and trastuzumab, however, slices were superior in detecting sunitinib cardiotoxicity and mechanism in the clinically relevant concentration range of 0.1–1 μM. These results indicate that heart slice culture models have the potential to become a reliable platform for testing and elucidating mechanisms of drug cardiotoxicity.
Original language | English (US) |
---|---|
Article number | 115213 |
Journal | Toxicology and Applied Pharmacology |
Volume | 406 |
DOIs | |
State | Published - Nov 1 2020 |
Funding
TMAM is supported by NIH grants R01HL147921 and P30GM127607 and American Heart Association grant 16SDG29950012. The authors also acknowledge NIH grants P30GM127607 (BGH), R01HL130174 (BGH), R01HL147844 (BGH), R01ES028268 (BGH), GM127607 (DJC), P01HL78825 (RB, BGH) and UM1HL113530 (RB), Leducq Foundation RHYTHM grant (IRE), R01HL126802 (IRE), R44HL139248 (IRE) and an American Heart Association Postdoctoral fellowship (19POST34370122) to SAG. We also acknowledge the USA Department of Defense for the grant W81XWH-20-1-0419 (JS, TMAM). We acknowledge the guidance of Ruslan Deviatiiarov from the Institute of Fundamental Medicine and Biology. Kazan Federal University, Russia in the Cap Analysis of Gene expression data analysis. TMAM is supported by NIH grants R01HL147921 and P30GM127607 and American Heart Association grant 16SDG29950012 . The authors also acknowledge NIH grants P30GM127607 (BGH), R01HL130174 (BGH), R01HL147844 (BGH), R01ES028268 (BGH), GM127607 (DJC), P01HL78825 (RB, BGH) and UM1HL113530 (RB), Leducq Foundation RHYTHM grant (IRE), R01HL126802 (IRE), R44HL139248 (IRE) and an American Heart Association Postdoctoral fellowship ( 19POST34370122 ) to SAG. We also acknowledge the USA Department of Defense for the grant W81XWH-20-1-0419 (JS, TMAM). We acknowledge the guidance of Ruslan Deviatiiarov from the Institute of Fundamental Medicine and Biology. Kazan Federal University, Russia in the Cap Analysis of Gene expression data analysis.
ASJC Scopus subject areas
- Toxicology
- Pharmacology